-
Study aim
-
Evaluation of the effect of TENS on severity of restless legs syndrome (RLS) in patients with this complaint
-
Design
-
The present study is a single blind randomized clinical trial. Patients who meet the eligibility criteria will be asked to complete a questionnaire. People with a score above 4 will be randomly divided into intervention and control groups (40 patients in each group).
-
Settings and conduct
-
The present study will be performed in the office of Internal medicine specialist. Both groups receive their usual treatment, which will be prescribed by an Internal medicine specialist. Before connecting them to the TENS device and after separating the device, RLS questionnaires will be completed.
To match the working process, the PM70 2-channel TENS device manufactured by Iran will be used.
-
Participants/Inclusion and exclusion criteria
-
People with suspected RLS who have diagnostic criteria for restless legs syndrome will receive an IRLSS questionnaire. Those with a score above 4 will be selected as the sample if they are eligible for the study. If they have a history of mental illness, vascular disease, neuromuscular disorders, experiencing a crisis for the past 3 months, taking antispasmodics, anticonvulsants, antidepressants, sedatives and herbal remedies and other non-pharmacological treatments during the past two weeks, will be excluded from the study.
-
Intervention groups
-
In this study, the TENS electric current is used at a frequency of 100 Hz, twice a week (Twice in total), and each time, for 20 minutes. Due to the location of the complication, the electrodes are attached to the extremities (legs) and their efficacy is evaluated according to the patient's condition. In the intervention group, the TENS device with HZ100 frequency will be used.
-
Main outcome variables
-
Severity of restless leg syndrom